Literature DB >> 30661038

Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.

Eugene S J Tan1, Wan Ting Tay2, Tiew-Hwa Katherine Teng2, David Sim2,3, Kui Toh Gerard Leong4, Poh Shuan Daniel Yeo5, Hean Yee Ong6, Fazlur Jaufeerally3,7, Tze Pin Ng8, Katrina Poppe9, Mayanna Lund10, Gerard Devlin11, Richard W Troughton12, Lieng Hsi Ling1, Arthur Mark Richards1,12,13, Robert N Doughty9, Carolyn S P Lam2,3,14.   

Abstract

OBJECTIVE: Ethnic differences in the prevalence of atrial fibrillation (AF) in heart failure (HF) remain unclear. We compared the prevalence and clinical correlates of AF among different ethnicities in an Asian-Pacific population with HF.
METHODS: Patients with validated HF were prospectively studied across Singapore and New Zealand (NZ).
RESULTS: Among 1746 patients with HF (62% Asian, 26% women, mean age 66 (SD 13) years, mean ejection fraction (EF) 37 (SD 16%), 39% had AF. The prevalence of AF was markedly lower in Singapore-Asians than NZ-Europeans (24% vs 63%; p<0.001), even after adjusting for age, clinical and echocardiographic covariates, regardless of EF group (pinteraction for EF=0.39). Patients with AF were older, had higher body mass index and were more likely to have a history of hypertension, stroke, peripheral vascular disease, renal disease, chronic respiratory disease and increased alcohol intake, but less likely to have diabetes. Clinical correlates were similar for Asians and NZ-Europeans, except diabetes: Asian diabetic patients with HF had less AF compared with Asian patients without diabetes (OR 0.66, 95% CI 0.50 to 0.88), whereas among NZ-Europeans there was no significant association between diabetes and AF (OR 1.22, 95% CI 0.85 to 1.75) (pinteraction for ethnicity=0.01). AF was associated with a higher crude composite outcome of mortality and HF hospitalisations at 2 years (HR 1.19, 95% CI 1.02 to 1.38).
CONCLUSION: There is a strikingly lower prevalence of AF among Asian compared with NZ-European patients with HF. The underlying mechanisms for the lower prevalence of AF among Asians, particularly in the presence of diabetes, deserve further study. TRIAL REGISTRATION NUMBER: ACTRN12610000374066. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  atrial fibrillation; diabetes; heart failure

Mesh:

Year:  2019        PMID: 30661038     DOI: 10.1136/heartjnl-2018-314077

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Ethnic differences in atrial fibrillation among patients with heart failure in Asia.

Authors:  Eugene S J Tan; Vera Goh; Bernadet T Santema; Wan Ting Tay; Tiew-Hwa Katherine Teng; Jonathan Yap; Jasper Tromp; Chung-Lieh Hung; Vijay Chopra; Inder Anand; Michael R MacDonald; Lieng Hsi Ling; Isabelle C Van Gelder; Michiel Rienstra; Adriaan A Voors; A Mark Richards; Carolyn S P Lam
Journal:  ESC Heart Fail       Date:  2020-05-08

2.  Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.

Authors:  Jonathan Yap; Wan Ting Tay; Tiew-Hwa Katherine Teng; Inder Anand; A Mark Richards; Lieng Hsi Ling; Michael R MacDonald; Chanchal Chandramouli; Jasper Tromp; Bambang B Siswanto; Michael Zile; John McMurray; Carolyn S P Lam
Journal:  J Am Heart Assoc       Date:  2019-08-21       Impact factor: 5.501

3.  Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation.

Authors:  Umut Kocabaş; Ümit Yaşar Sinan; Emre Aruğaslan; Mustafa Kurşun; Ali Çoner; Özlem Özcan Çelebi; Cengiz Öztürk; Onur Dalgıç; Ebru Ipek Türkoğlu; Hatice Soner Kemal; Emine Gazi; Cihan Altın; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2020-04       Impact factor: 1.596

4.  Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.

Authors:  Li Shen; Rasmus Rørth; Deborah Cosmi; Søren Lund Kristensen; Mark C Petrie; Franco Cosmi; Roberto Latini; Lars Køber; Inder S Anand; Peter E Carson; Christopher B Granger; Michel Komajda; Robert S McKelvie; Scott D Solomon; Lidia Staszewsky; Karl Swedberg; Thao Huynh; Michael R Zile; Pardeep S Jhund; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2019-07-04       Impact factor: 15.534

5.  Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.

Authors:  Christophe Beauloye; Anne-Catherine Pouleur; Sibille Lejeune; Clotilde Roy; Alisson Slimani; Agnès Pasquet; David Vancraeynest; Jean-Louis Vanoverschelde; Bernhard L Gerber
Journal:  Cardiovasc Diabetol       Date:  2021-02-19       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.